Publications by authors named "Sisi Fu"

Background/objectives: Activating brown adipose tissue (BAT) and browning of white adipose tissue (WAT) can protect against obesity and obesity-related metabolic conditions. Cryptotanshinone (CT) regulates lipid metabolism and significantly ameliorates insulin resistance. Adenosine-5'-monophosphate (AMP)-activated protein kinase (AMPK), a receptor for cellular energy metabolism, is believed to regulate brown fat activity in humans.

View Article and Find Full Text PDF
Article Synopsis
  • Sovleplenib, a new SYK inhibitor, showed effective results and safety in treating patients with chronic primary immune thrombocytopenia in a phase 3 trial conducted in China.
  • The trial involved 188 participants who were given either sovleplenib or a placebo, with results showing a significant durable response rate of 48% for sovleplenib compared to 0% for the placebo group.
  • The study demonstrated a faster median time to response of 8 days for patients on sovleplenib versus 30 days for those receiving placebo, highlighting its potential efficacy in this condition.
View Article and Find Full Text PDF
Article Synopsis
  • - Sovleplenib (HMPL-523) is an experimental drug designed to target and inhibit spleen tyrosine kinase (Syk), showing potential effectiveness against B-cell cancers in early research.
  • - A Phase I clinical trial was conducted with 134 patients suffering from relapsed or refractory B-cell tumors, exploring different dosages of the drug (200-800 mg daily); the recommended phase II dose was established at 600 mg for heavier patients and 400 mg for lighter ones.
  • - The study found a 50.8% objective response rate in a subset of patients with indolent B-cell lymphoma, while some patients reported severe side effects, but overall, sovleplenib demonstrated promising anti-t
View Article and Find Full Text PDF

Numerous works have been focused on the bioactivities of protein hydrolysates (PHs) and their application in food or drug formulations, but their composition and pharmacokinetics have never been addressed due to their complex constitutes, short half-life, extremely low concentrations and lack of authentic standards. The present study aims to develop systematic analytical strategy and technical platform with optimized sample preparation, separation and detection protocols for PHs. Lineal peptides (LPs), extraction of the spleen of healthy pigs or calves, were used as cases.

View Article and Find Full Text PDF

Both NLRP3 inflammasome and Th17 cells play important roles in the pathogenesis of systemic lupus erythematosus (SLE). Here we tried to investigate whether leptin promotes the differentiation of Th17 cells from lupus mice by activating the NLRP3 inflammasome. Th17 cells induced from MRL/Mp-Fas lpr mice splenocytes under Th17 polarizing condition were treated with leptin at scalar doses during the last 18 h of culture.

View Article and Find Full Text PDF

Gouty arthritis is an inflammatory disease that is triggered by abnormal uric acid metabolism, which is usually attributed to obesity, a risk factor of hyperuricemia and gout attack. A high level of leptin in plasma is a marker of individuals with obesity. Population studies show that leptin promotes obesity-related arthritis, such as osteoarthritis, but it is unknown whether leptin contributes to gouty arthritis, another form of obesity-related arthritis.

View Article and Find Full Text PDF

Leptin is a cytokine‑like hormone secreted by adipocytes, which serves to control energy expenditure and metabolism. In addition, leptin may modulate the innate and adaptive immune responses. The innate immune cell sensor nucleotide‑binding oligomerization domain‑like receptor family pyrin domain‑containing 3 (NLRP3) inflammasome is mainly expressed in myeloid immune cells, including macrophages.

View Article and Find Full Text PDF